5-heteroaryl substituted indazoles as kinase inhibitors

Details for Australian Patent Application No. 2008262038 (hide)

Owner Abbott Laboratories Abbott GmbH & Co. KG

Inventors Patel, Jyoti R.; Vasudevan, Anil; Wakefield, Brian D.; Gasiecki, Alan F.; Hobson, Adrian; Gracias, Vijaya J.; Akritopoulou-Zanze, Irini; Shuai, Qi; Frank, Kristine; Djuric, Stevan W.; St. John Moore, Nigel; George, Dawn; Li, Biqin; Turner, Sean C.; Michmerhuizen, Melissa J.; Sarris, Kathy; Teusch, Nicole; Kovar, Peter J.; Wang, Lu; Long, Andrew J.; Bakker, Margaretha; Mack, Helmut; Johnson, Eric T.; Kalvin, Douglas M.

Agent Spruson & Ferguson

Pub. Number AU-A-2008262038

PCT Pub. Number WO2008/154241

Priority 60/933,960 08.06.07 US

Filing date 4 June 2008

Wipo publication date 18 December 2008

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/154241 Priority application(s): WO2008/154241

25 March 2010 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Johnson, Eric T. to Johnson, Eric F.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262048-C3b antibodies and methods for the prevention and treatment of complementassociated disorders

2008262031-Extended release formulation of nevirapine